The development and extensive marketing of cosmetics containing cannabinoids—primarily CBD—has occurred in the absence of solid scientific evidence of their efficacy. Can cannabinoids even be absorbed into skin and, if so, can they have beneficial health effects? A...
The increasing value of both recreational and medicinal cannabis around the world is driving a need to purify large quantities of full-spectrum and individual cannabinoids for use in vapes, beverages, and capsules. BioHarvest—a plant-cell growth company—has announced...
As cannabis vaping pens grew in popularity in late 2019, concerns grew about the safety of the products, spurred by reports of illness, and even deaths, of tobacco vape users. Vape manufacturers rushed to assure regulators and consumers their products were safe,...
Cannabis-related emergency department visits are thought to have more than tripled between 2011 and 2019, coincident with the legalization of recreational and medical cannabis in many US states. Yet there are no approved drugs to treat overdoses due to cannabis or...
For years, word-of-mouth has pointed to the benefit of using cannabis to treat symptoms of post-traumatic stress disorder (PTSD). Yet, despite medical cannabis having been authorized by 24 US states for the treatment of PTSD, most doctors won’t prescribe it for their...
Researchers in Slovenia may have found a solution to one of the biggest issues regarding cannabis testing and labeling. Consumers looking for high-THC content or a particular terpene profile in a cannabis product regularly express their desire for more explicit...
On December 17, the Federal Trade Commission (FTC) announced its first crackdown on deceptive marketing claims for CBD products. These claims cover a range of scientifically unsupported benefits, including cancer, heart disease, hypertension, and Alzheimer’s disease, and also include allegations that at least one company made false claims about scientific findings.
Here's a look back at the year that was through the lens of MJBizDaily's most-read marijuana business stories of 2020.
We’re learning a lot about the ways THC and CBD interact with the endocannabinoid system (ECS) to stimulate appetite and help treat pain, anxiety, and epileptic seizures. But cannabis contains a vast array of minor cannabinoids as well. What is their therapeutic potential and how do they work in the body?
A California life sciences company named Biomedican is drawing significant attention for the rapid progress it’s made in patented, low-cost methods of biosynthesizing rare cannabinoids.
A new study shows consumers are unable to identify cannabinoid levels in products they use. Further, 20-50 percent don’t know the THC:CBD ratio of the products they normally use. This lack of consumer awareness could have implications for the safety and efficacy of...
This article was originally published on The Cannigma and appears here with permission. What happened when researchers took thousands of cannabis samples representing 396 strain names to a laboratory? The analyzed samples turned out to be a whopping three distinct...
